receive up to $150,000 in funding to study ways to improve care and help find cures for people with breast, colorectal, pancreatic, and small cell lung cancer, as well as pediatric acute myeloid leukemia. The NCCN Oncology Research Program (ORP) managed
Search Results
H. Joachim Deeg and Marcos de Lima
outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation . J Clin Oncol 2007 ; 25 : 4246 – 4254 . 10. Sorror ML Storer B Sandmaier BM . Allogeneic hematopoietic cell
Margaret R. O'Donnell
. She was looking to identify ways to address the discordance between an extrapolation of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) combined with the SEER database of annual incidence of acute myeloid leukemia (AML) in patients
Briony Shaw, Catriona Parker, Stephen Opat, Jake Shortt, and Peter Poon
data and 229 were available for analysis ( Figure 1 ). Median age was 77 years (range, 24–99 years), with 35% female and 58% born outside Australia. Other demographics are described in Table 1 . Acute myeloid leukemia was the most frequent diagnosis
Benyam Muluneh
after I finished speaking with the daughter (let’s call her Beth) of a patient who was starting an oral anticancer drug (venetoclax) for acute myeloid leukemia. I explained to Beth that although she was “told” the treatment would start next week, it all
NCCN Guidelines. Presentations included treatment updates and patient case studies on: Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Myeloid Leukemia Diffuse Large B
as Vice President of Community and Support for an online virtual world. He holds a bachelor's degree in Computer and Information Sciences from the University of Massachusetts. In November 2010, Mr. Greene was diagnosed with acute myeloid leukemia
Peter L. Greenberg, Richard M. Stone, Rafael Bejar, John M. Bennett, Clara D. Bloomfield, Uma Borate, Carlos M. De Castro, H. Joachim Deeg, Amy E. DeZern, Amir T. Fathi, Olga Frankfurt, Karin Gaensler, Guillermo Garcia-Manero, Elizabeth A. Griffiths, David Head, Virginia Klimek, Rami Komrokji, Lisa A. Kujawski, Lori J. Maness, Margaret R. O’Donnell, Daniel A. Pollyea, Bart Scott, Paul J. Shami, Brady L. Stein, Peter Westervelt, Benton Wheeler, Dorothy A. Shead, and Courtney Smith
acute myeloid leukemia (AML) evolution. It should NCCN Guidelines Insights : Myelodysplastic Syndromes, Version 2.2015 Version 2.2015 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this
Kah Poh Loh, Vivian Lam, Katey Webber, Simran Padam, Mina S. Sedrak, Vivek Musinipally, Madison Grogan, Carolyn J. Presley, Janice Grandi, Chandrika Sanapala, Daniel A. Castillo, Grace DiGiovanni, Supriya G. Mohile, Louise C. Walter, and Melisa L. Wong
– 43 , 46 , 51 , 56 examined characteristics associated with functional improvement. Three articles 34 , 51 , 56 reporting results of a study of acute myeloid leukemia found that younger age was associated with greater improvement in timed chair
Jeffrey Crawford, Pamela Sue Becker, James O. Armitage, Douglas W. Blayney, Julio Chavez, Peter Curtin, Shira Dinner, Thomas Fynan, Ivana Gojo, Elizabeth A. Griffiths, Shannon Hough, Dwight D. Kloth, David J. Kuter, Gary H. Lyman, Mary Mably, Sudipto Mukherjee, Shiven Patel, Lia E. Perez, Adam Poust, Raajit Rampal, Vivek Roy, Hope S. Rugo, Ayman A. Saad, Lee S. Schwartzberg, Sepideh Shayani, Mahsa Talbott, Saroj Vadhan-Raj, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, Jennifer L. Burns, and Lenora Pluchino
. Additional indications for filgrastim and filgrastim-sndz include treatment for patients with acute myeloid leukemia (AML) receiving induction or consolidation chemotherapy, patients with cancer receiving bone marrow transplant, patients undergoing peripheral
